Literature DB >> 3499462

Analysis of the antigen- and mitogen-induced differentiation of B lymphocytes from asymptomatic human immunodeficiency virus-seropositive male homosexuals. Discrepancy between T cell-dependent and T cell-independent activation.

V J Teeuwsen1, T Logtenberg, K H Siebelink, J M Lange, J Goudsmit, F G Uytdehaag, A D Osterhaus.   

Abstract

Five asymptomatic human immunodeficiency virus (HIV)-seropositive male homosexuals were immunized with the recall antigens tetanus toxoid (TT) and the three types of poliovirus present in diphtheria, tetanus, and polio vaccine. Four weeks after immunization, the in vivo response to booster immunization, the in vitro pokeweed mitogen (PWM)-induced IgG secretion, and the in vitro T cell-dependent and T cell-independent antigen-induced antibody response were assayed. Increase in serum antibody titer to TT and poliovirus was low and normal, respectively. In all five subjects studied, a high rate of spontaneous IgG production, including antibodies directed toward HIV was observed. Addition of PWM to the cultures induced suppression of the spontaneous IgG secretion. Only one donor showed a slightly increased IgG production after stimulation with PWM. Peripheral blood mononuclear cells of four of the five HIV-seropositive individuals did not produce TT, or poliovirus-specific antibodies when stimulated with the respective T cell-dependent antigens. However, stimulation of these peripheral blood mononuclear cells with TT coupled to agarose beads, which was shown to be T cell-independent, resulted in the generation of IgG anti-TT antibody-forming cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3499462

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Antibody responses in HIV infection.

Authors:  A J Pinching
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

Review 2.  B cell responses to HIV and the development of human monoclonal antibodies.

Authors:  J E Boyd; K James
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

3.  Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients.

Authors:  M Opravil; W Fierz; L Matter; J Blaser; R Lüthy
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

4.  Immunological responses of Gambians in relation to clinical stage of HIV-2 disease.

Authors:  H Whittle; A Egboga; J Todd; G Morgan; M Rolfe; S Sabally; A Wilkins; T Corrah
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

Review 5.  HIV-mediated B-lymphocyte activation and lymphomagenesis.

Authors:  J G Monroe; L E Silberstein
Journal:  J Clin Immunol       Date:  1995-03       Impact factor: 8.317

6.  In vitro anti-HIV-1 antibody production in subjects in different stages of HIV-1 infection.

Authors:  S Rusconi; A Riva; L Meroni; G Zehender; F Cocchi; L Scapellato; M Galli
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

7.  Lymphocyte subset alterations and viral determinants of immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS.

Authors:  S L Quackenbush; P R Donahue; G A Dean; M H Myles; C D Ackley; M D Cooper; J I Mullins; E A Hoover
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

8.  Lymphocyte transformation responses to phytohaemagglutinin and pokeweed mitogen in patients at differing stages of HIV infection: are they worth measuring?

Authors:  A S Bansal; A Moran; M Potter; R Taylor; M R Haeney; B K Mandal
Journal:  J Clin Pathol       Date:  1993-09       Impact factor: 3.411

9.  In vitro synthesis of human immunodeficiency virus-specific antibodies in peripheral blood lymphocytes of infants.

Authors:  S Pahwa; N Chirmule; C Leombruno; W Lim; R Harper; R Bhalla; R Pahwa; R P Nelson; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.